Institutional investors purchased a net $135.0 thousand shares of PBMD during the quarter ended June 2016 and now own 0.34% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
UBS SECURITIES LLC Bought 107.2 Thousand shares of Prima BioMed Ltd
NOMURA SECURITIES CO., LTD. (PRI... Bought 37.2 Thousand shares of Prima BioMed Ltd
G1 EXECUTION SERVICES LLC Bought 11.8 Thousand shares of Prima BioMed Ltd